VJHemOnc Podcast

VJHemOnc

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

266 Episoder

Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents
18.12.2024
28:53
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by involvement of the skin, bone... The post Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents appeared first on VJHemOnc.
Improving care for patients with SCD: pain management, ongoing projects & unmet needs
5.12.2024
16:45
This week’s podcast focuses on strategies to improve care for patients with sickle cell disease (SCD), featuring expert insights from... The post Improving care for patients with SCD: pain management, ongoing projects & unmet needs appeared first on VJHemOnc.
Gå ikke glip af nogen episoder af “VJHemOnc Podcast” - abonnér på podcasten med gratisapp GetPodcast.
Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care
28.11.2024
34:43
In this podcast, experts Marlise Luskin, MD, MSCE, Dana-Farber Cancer Institute, Boston, MA, Nicole LeBoeuf, MD, MPH, Dana-Farber Cancer Institute,... The post Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care appeared first on VJHemOnc.
Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more!
19.11.2024
21:37
Today’s podcast episode focuses on the management of complications associated with Waldenström’s macroglobulinemia (WM), featuring expert insights from the 12th... The post Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more! appeared first on VJHemOnc.
CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024
12.11.2024
24:59
This week’s podcast features discussions on the use of immunotherapy in the treatment of high-risk multiple myeloma (HRMM) from the... The post CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024 appeared first on VJHemOnc.
The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS
6.11.2024
22:39
This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix,... The post The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS appeared first on VJHemOnc.
Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events
30.10.2024
9:30
Today’s podcast focuses on the role of BTK inhibitors (BTKis) in the treatment of mantle cell lymphoma (MCL). You will... The post Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events appeared first on VJHemOnc.
An update on menin inhibition in AML from iwAL 2024: current data, mechanisms of resistance, & more!
23.10.2024
16:35
Menin inhibitors are emerging as a promising therapeutic approach in acute myeloid leukemia (AML), particularly in patients with specific genetic... The post An update on menin inhibition in AML from iwAL 2024: current data, mechanisms of resistance, & more! appeared first on VJHemOnc.
CAR T-cells and bispecific antibodies in the treatment of NHL: updates from iwNHL 2024
15.10.2024
20:31
Today’s podcast features discussions from the 21st International Workshop on Non-Hodgkin Lymphoma (iwNHL) which took place in Nice, France. You... The post CAR T-cells and bispecific antibodies in the treatment of NHL: updates from iwNHL 2024 appeared first on VJHemOnc.
Prolonging remission in AML: current approaches & future outlooks
8.10.2024
31:28
Today’s podcast features a discussion with leading experts Harry Erba, MD, PhD, Duke University, Durham, NC, Farhad Ravandi, MD, The... The post Prolonging remission in AML: current approaches & future outlooks appeared first on VJHemOnc.

Flere episoder

Få adgang til hele det store podcastunivers med gratisappen GetPodcast.

Abonnér på dine favoritpodcasts, lyt til episoder offline, og få spændende anbefalinger.

Privatlivspolitik
Kolofon
Danmark

VJHemOnc Podcast

VJHemOnc

266 Episoder

Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents

Improving care for patients with SCD: pain management, ongoing projects & unmet needs

Understanding BPDCN: dermatology and hematology perspectives on presentation, diagnosis, treatment, & multidisciplinary care

Managing complications associated with WM: Bing-Neel syndrome, acquired von Willebrand disease, & more!

CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024

The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS

Exploring the role of BTK inhibitors in mantle cell lymphoma: sequencing & managing adverse events

An update on menin inhibition in AML from iwAL 2024: current data, mechanisms of resistance, & more!

CAR T-cells and bispecific antibodies in the treatment of NHL: updates from iwNHL 2024

Prolonging remission in AML: current approaches & future outlooks